• Define virologic blips, low-level viremia, and virologic failure, and apply these concepts to the evaluation of patients with detectable HIV viremia.
  • Interpret HIV resistance testing by distinguishing the roles and limitations of plasma genotypic, phenotypic, and proviral DNA resistance assays and incorporating historical resistance results into clinical decision-making.
  • Compare the resistance characteristics of the major antiretroviral drug classes and explain how these principles influence the management of treatment-experienced patients with HIV.
Session date: 
08/05/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center (Virtual)
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.